Marker combination of product for relieving hypercoagulable state of lung cancer, establishment and application method of curative effect discrimination model and traditional Chinese medicine combination

The invention discloses a marker combination of a product for relieving a hypercoagulable state of lung cancer, establishment and application methods of a curative effect discrimination model and a traditional Chinese medicine composition, the marker combination comprises D-D and FIB, based on clini...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CHEN WEI, CHEN JIABIN, ZHOU YING, HU QINQIN, DU YUXUAN, WANG SHENG, CHEN YUTENG, CHAI KEQUN
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention discloses a marker combination of a product for relieving a hypercoagulable state of lung cancer, establishment and application methods of a curative effect discrimination model and a traditional Chinese medicine composition, the marker combination comprises D-D and FIB, based on clinical real diagnosis and treatment data, two specific indexes D-D and FIB are obtained after screening, and the curative effect discrimination model can be used for treating the hypercoagulable state of lung cancer. A logistic regression model is established after multi-factor analysis and is used for judging the curative effect of intervening the hypercoagulable state, and compared with traditional index detection, the method has better accuracy and feasibility. Furthermore, based on the clinical curative effect, association rule analysis is performed on the used traditional Chinese medicine prescription according to the traditional Chinese medicine syndrome type, a corresponding traditional Chinese medicine composi